Citations (60)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Siyuan Hao, Jiahe Wang & Yan Wang. (2021) Effectiveness and safety of Bifidobacterium in preventing dental caries: a systematic review and meta-analysis. Acta Odontologica Scandinavica 79:8, pages 613-622.
Read now
Read now
David A. Mills. (2017) Probiotic nomenclature matters redux: confusion on Bifidobacterium longum subsp. infantis taxonomy persists. Current Medical Research and Opinion 33:11, pages 2097-2097.
Read now
Read now
Andrew P. Allen, Gerard Clarke, John F. Cryan, Eamonn M. M. Quigley & Timothy G. Dinan. (2017) Bifidobacterium infantis 35624 and other probiotics in the management of irritable bowel syndrome. Strain specificity, symptoms, and mechanisms. Current Medical Research and Opinion 33:7, pages 1349-1351.
Read now
Read now
Articles from other publishers (57)
James D Brunner & Nicholas Chia. (2024) Metabolic model-based ecological modeling for probiotic design. eLife 13.
Crossref
Crossref
Nicoleta-Maricica Maftei, Cosmin Raducu Raileanu, Alexia Anastasia Balta, Lenuta Ambrose, Monica Boev, Denisa Batîr Marin & Elena Lacramioara Lisa. (2024) The Potential Impact of Probiotics on Human Health: An Update on Their Health-Promoting Properties. Microorganisms 12:2, pages 234.
Crossref
Crossref
M. Amieva-Balmori, J.F. García-Mazcorro, A. Martínez-Conejo, G.A. Hernández-Ramírez, K.R. García-Zermeño, O. Rodríguez-Aguilera, M. Aja-Cadena, M. Barradas-Cortés, E.M.M. Quigley & J.M. Remes-Troche. (2023) Fecal bacterial microbiota in constipated patients before and after eight weeks of daily Bifidobacterium infantis 35624 administration. Revista de Gastroenterología de México (English Edition) 88:4, pages 369-380.
Crossref
Crossref
M. Amieva-Balmori, J.F. García-Mazcorro, A. Martínez-Conejo, G.A. Hernández-Ramírez, K.R. García-Zermeño, O. Rodríguez-Aguilera, M. Aja-Cadena, M. Cortes-Barradas, E.M.M. Quigley & J.M. Remes-Troche. (2023) La microbiota bacteriana fecal en pacientes estreñidos previa y posterior a ocho semanas de administración diaria de Bifidobacterium infantis 35624. Revista de Gastroenterología de México 88:4, pages 369-380.
Crossref
Crossref
Inês Terra, Catarina Santeiro & Jenifer da Fonseca Rua. (2023) Supplementation With Bifidobacterium and Symptomatic Control in Irritable Bowel Syndrome: An Evidence-Based Review. Cureus.
Crossref
Crossref
Efthymios P Tsounis, Christos Triantos, Christos Konstantakis, Markos Marangos & Stelios F Assimakopoulos. (2023) Intestinal barrier dysfunction as a key driver of severe COVID-19. World Journal of Virology 12:2, pages 68-90.
Crossref
Crossref
Agnes Czibulka. 2023. Functional Illness of the Head and Neck. Functional Illness of the Head and Neck
291
306
.
E. S. Klimenko, N. L. Belkova, A. V. Pogodina, L. V. Rychkova & M. A. Darenskaya. (2022) Comorbidity of functional bowel disorders and obesity in terms of microbiome. Acta Biomedica Scientifica 7:5-2, pages 56-66.
Crossref
Crossref
Sasipa Sangkanjanavanich, Panitan Pradubpongsa, Wat Mitthamsiri, Atik Sangasapaviliya & Tadech Boonpiyathad. (2022) Bifidobacterium infantis 35624 efficacy in patients with uncontrolled asthma: A randomized placebo-controlled trial. Annals of Allergy, Asthma & Immunology 129:6, pages 790-792.
Crossref
Crossref
Seung Yong Shin, Sein Park, Jung Min Moon, Kisung Kim, Jeong Wook Kim, Jongsik Chun, Tae Hee Lee & Chang Hwan Choi. (2022) Compositional Changes in the Gut Microbiota of Responders and Non-responders to Probiotic Treatment Among Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Post Hoc Analysis of a Randomized Clinical Trial. Journal of Neurogastroenterology and Motility 28:4, pages 642-654.
Crossref
Crossref
Agnes Czibulka. (2022) Probiotics for Otolaryngologic Disorders. Otolaryngologic Clinics of North America 55:5, pages 939-946.
Crossref
Crossref
Linling Lv, Guangcong Ruan, Yi Ping, Yi Cheng, Yuting Tian, Zhifeng Xiao, Xuefei Zhao, Dongfeng Chen & Yanling Wei. (2022) Clinical study on sequential treatment of severe diarrhea irritable bowel syndrome with precision probiotic strains transplantation capsules, fecal microbiota transplantation capsules and live combined bacillus subtilis and enterococcus faecium capsules. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Chengting Chang, Xingzhu Yuan, Xingxia Zhang, Xinrong Chen & Ka Li. (2022) Gastrointestinal Microbiome and Multiple Health Outcomes: Umbrella Review. Nutrients 14:18, pages 3726.
Crossref
Crossref
Antonia Piazzesi & Lorenza Putignani. (2022) Extremely small and incredibly close: Gut microbes as modulators of inflammation and targets for therapeutic intervention. Frontiers in Microbiology 13.
Crossref
Crossref
D. I. Trukhan. (2022) Disorders of intestinal microbiocenosis: expanding the application of probiotics. Meditsinskiy sovet = Medical Council:7, pages 132-143.
Crossref
Crossref
Antonios Kioukis, Mohsen Pourjam, Klaus Neuhaus & Ilias Lagkouvardos. (2022) Taxonomy Informed Clustering, an Optimized Method for Purer and More Informative Clusters in Diversity Analysis and Microbiome Profiling. Frontiers in Bioinformatics 2.
Crossref
Crossref
Panoraia Bousdouni, Aikaterini Kandyliari & Antonios E. Koutelidakis. (2022) Probiotics and Phytochemicals: Role on Gut Microbiota and Efficacy on Irritable Bowel Syndrome, Functional Dyspepsia, and Functional Constipation. Gastrointestinal Disorders 4:1, pages 30-48.
Crossref
Crossref
Zhendong Zhang, Qiangchuan Hou, Yurong Wang, Fanshu Xiang & Zhuang Guo. (2022) Evaluation of Bacterial Diversity and Evolutionary Dynamics of Gut Bifidobacterium longum Isolates Obtained from Older Individuals in Hubei Province, China. Microbiology Spectrum 10:1.
Crossref
Crossref
Adelina Nicoleta Galica, Reitano Galica & Dan Lucian Dumitrașcu. (2022) Diet, fibers, and probiotics for irritable bowel syndrome. Journal of Medicine and Life 15:2, pages 174-179.
Crossref
Crossref
Sae-Ryung Kang, Dinh-Huy Nguyen, Su Woong Yoo & Jung-Joon Min. (2022) Bacteria and bacterial derivatives as delivery carriers for immunotherapy. Advanced Drug Delivery Reviews 181, pages 114085.
Crossref
Crossref
Lynne V. McFarland, Tarkan Karakan & Ali Karatas. (2021) Strain-specific and outcome-specific efficacy of probiotics for the treatment of irritable bowel syndrome: A systematic review and meta-analysis. eClinicalMedicine 41, pages 101154.
Crossref
Crossref
Angelica Varesi, Undine-Sophie Deumer, Sanjana Ananth & Giovanni Ricevuti. (2021) The Emerging Role of Gut Microbiota in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Current Evidence and Potential Therapeutic Applications. Journal of Clinical Medicine 10:21, pages 5077.
Crossref
Crossref
Trudy M. Wassenaar, Valentina A. Juncos & Kurt Zimmermann. (2021) Interactions between the Gut Microbiome, Lung Conditions, and Coronary Heart Disease and How Probiotics Affect These. International Journal of Molecular Sciences 22:18, pages 9700.
Crossref
Crossref
Muhammad Aziz, Jaya Kumar, Khairul Muhammad Nawawi, Raja Raja Ali & Norfilza Mokhtar. (2021) Irritable Bowel Syndrome, Depression, and Neurodegeneration: A Bidirectional Communication from Gut to Brain. Nutrients 13:9, pages 3061.
Crossref
Crossref
K. V. Ivashkin, V. R. Grechishnikova, M. S. Reshetova & V. T. Ivashkin. (2021) Irritable Bowel and Bacterial Overgrowth Syndromes: a Bacterial Link Hypothesis of Functional Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 31:1, pages 54-63.
Crossref
Crossref
E. Yu. Plotnikova. (2021) Unique strain of Bifidobacterium longum and its efficacy in irritable bowel syndrome. Meditsinskiy sovet = Medical Council:21, pages 144-150.
Crossref
Crossref
Tao Bai, Haoyu Zeng, Yanqin Long, Xiaoqing Li, Xiaohong Sun, Yu Lan, Lingling Gao, Lu Zhang, Zenghui Feng & Xiaohua Hou. (2020) The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial. Trials 21:1.
Crossref
Crossref
. (2020)
Ueg
Week 2020 Poster Presentations
. United European Gastroenterology Journal 8:S8, pages 144-887.
Crossref
Crossref
Ying Li, Gaichao Hong, Min Yang, Gangping Li, Yu Jin, Hanhua Xiong, Wei Qian & Xiaohua Hou. (2020) Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome. Pharmacological Research 159, pages 104936.
Crossref
Crossref
Min Ji Kim, Yang Won Min, Chansu Lee, Yeon Sil Jang, Cheol Hyun Kim & Dong Kyung Chang. (2020) The effects of three novel probiotics isolated from the Korean fermented food Kimchi on the stress-induced defecation of rats. Precision and Future Medicine 4:1, pages 31-36.
Crossref
Crossref
Roshan Kumar, Utkarsh Sood, Vipin Gupta, Mona Singh, Joy Scaria & Rup Lal. (2019) Recent Advancements in the Development of Modern Probiotics for Restoring Human Gut Microbiome Dysbiosis. Indian Journal of Microbiology 60:1, pages 12-25.
Crossref
Crossref
I.A.M. van Thiel, S. Botschuijver, W.J. de Jonge & J. Seppen. (2020) Painful interactions: Microbial compounds and visceral pain. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1866:1, pages 165534.
Crossref
Crossref
Natalie Ramsy & Sonia Michail. 2020. Encyclopedia of Gastroenterology. Encyclopedia of Gastroenterology
289
298
.
Parisa Rahmani, Alireza Moradzadeh & Fatemeh Farahmand. (2019) Giving probiotics to your children for gastrointestinal problems: In the light of scientific findings. PharmaNutrition 10, pages 100164.
Crossref
Crossref
Floriane Gaucher, Koffigan Kponouglo, Houem Rabah, Sylvie Bonnassie, Jordane Ossemond, Sandrine Pottier, Julien Jardin, Valérie Briard-Bion, Pierre Marchand, Philippe Blanc, Romain Jeantet & Gwénaël Jan. (2019) Propionibacterium freudenreichii CIRM-BIA 129 Osmoadaptation Coupled to Acid-Adaptation Increases Its Viability During Freeze-Drying. Frontiers in Microbiology 10.
Crossref
Crossref
Yuan Jia, Li-Min Guo, Si-Yuan Yang, Qian Wu & Fan-Jie Meng. (2019) Effectiveness of probiotics in irritable bowel syndrome: methodological quality of meta-analyses and systematic reviews. Frontiers of Nursing 6:2, pages 115-121.
Crossref
Crossref
Pei Pei Chong, Voon Kin Chin, Chung Yeng Looi, Won Fen Wong, Priya Madhavan & Voon Chen Yong. (2019) The Microbiome and Irritable Bowel Syndrome – A Review on the Pathophysiology, Current Research and Future Therapy. Frontiers in Microbiology 10.
Crossref
Crossref
Soo Liang Ooi, Dianne Correa & Sok Cheon Pak. (2019) Probiotics, prebiotics, and low FODMAP diet for irritable bowel syndrome – What is the current evidence?. Complementary Therapies in Medicine 43, pages 73-80.
Crossref
Crossref
Jordan Shapiro, Jessica Bernica & Ruben Hernaez. (2019) Risk of Bias Analysis of Systematic Reviews of Probiotics for Treatment of Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology 17:4, pages 784-785.
Crossref
Crossref
D. I. Trukhan, V. V. Goloshubina & D. S. Ivanova. (2019) Actual issues of diagnosis and treatment of irritable bowel syndrome. Medical Council:21, pages 110-116.
Crossref
Crossref
Dervla O'Malley. (2018) Endocrine regulation of gut function – a role for glucagon‐like peptide‐1 in the pathophysiology of irritable bowel syndrome. Experimental Physiology 104:1, pages 3-10.
Crossref
Crossref
Dan Cristian Vodnar, Lavinia Florina Călinoiu, Laura Mitrea, Gabriela Precup, Maria Bindea, Andrea Mariana Păcurar, Katalin Szabo & Bianca Eugenia Ştefănescu. 2019. Functional and Medicinal Beverages. Functional and Medicinal Beverages
483
528
.
Agnes Czibulka. 2019. Laryngopharyngeal Reflux Disease. Laryngopharyngeal Reflux Disease
103
113
.
Izabella Mogilnicka & Marcin Ufnal. (2018) Gut Mycobiota and Fungal Metabolites in Human Homeostasis. Current Drug Targets 20:2, pages 232-240.
Crossref
Crossref
Michael Camilleri. (2018) Management Options for Irritable Bowel Syndrome. Mayo Clinic Proceedings 93:12, pages 1858-1872.
Crossref
Crossref
S. M. Zakharenko. (2018) Probiotics: a new or an old concept?. Medical Council:14, pages 56-60.
Crossref
Crossref
Yuying Liu, Dat Q. Tran & J. Marc Rhoads. (2018) Probiotics in Disease Prevention and Treatment. The Journal of Clinical Pharmacology 58:S10.
Crossref
Crossref
Niv Zmora, Gili Zilberman-Schapira, Jotham Suez, Uria Mor, Mally Dori-Bachash, Stavros Bashiardes, Eran Kotler, Maya Zur, Dana Regev-Lehavi, Rotem Ben-Zeev Brik, Sara Federici, Yotam Cohen, Raquel Linevsky, Daphna Rothschild, Andreas E. Moor, Shani Ben-Moshe, Alon Harmelin, Shalev Itzkovitz, Nitsan Maharshak, Oren Shibolet, Hagit Shapiro, Meirav Pevsner-Fischer, Itai Sharon, Zamir Halpern, Eran Segal & Eran Elinav. (2018) Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features. Cell 174:6, pages 1388-1405.e21.
Crossref
Crossref
Lynne V. McFarland, Charlesnika T. Evans & Ellie J. C. Goldstein. (2018) Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis. Frontiers in Medicine 5.
Crossref
Crossref
A. P. S. Hungin, C. R. Mitchell, P. Whorwell, C. Mulligan, O. Cole, L. Agréus, P. Fracasso, C. Lionis, J. Mendive, J.‐M. Philippart de Foy, B. Seifert, K.‐A. Wensaas, C. Winchester & N. de Wit. (2018) Systematic review: probiotics in the management of lower gastrointestinal symptoms – an updated evidence‐based international consensus. Alimentary Pharmacology & Therapeutics 47:8, pages 1054-1070.
Crossref
Crossref
Pablo Roman, Raquel AbaloEva M. Marco & Diana Cardona. (2018) Probiotics in digestive, emotional, and pain-related disorders. Behavioural Pharmacology 29:2 and 3, pages 103-119.
Crossref
Crossref
Bruno K. Rodiño-Janeiro, María Vicario, Carmen Alonso-Cotoner, Roberto Pascua-García & Javier Santos. (2018) A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies. Advances in Therapy 35:3, pages 289-310.
Crossref
Crossref
Akinori Yanaka. (2018) Daily intake of broccoli sprouts normalizes bowel habits in human healthy subjects. Journal of Clinical Biochemistry and Nutrition 62:1, pages 75-82.
Crossref
Crossref
Jing Zhang, Feng-Gang Ren, Peng Liu, Hong-Ke Zhang, Hao-Yang Zhu, Zhe Feng, Xu-Feng Zhang, Bo Wang, Xue-Ming Liu, Xiao-Gang Zhang, Rong-Qian Wu & Yi Lv. (2017) Characteristics of fecal microbial communities in patients with non-anastomotic biliary strictures after liver transplantation. World Journal of Gastroenterology 23:46, pages 8217-8226.
Crossref
Crossref
Eirini Dimidi, Megan Rossi & Kevin Whelan. (2017) Irritable bowel syndrome and diet. Current Opinion in Clinical Nutrition & Metabolic Care 20:6, pages 456-463.
Crossref
Crossref
Katherine A. Lyseng-Williamson. (2017) Bifidobacterium infantis 35624 as a probiotic dietary supplement: a profile of its use. Drugs & Therapy Perspectives 33:8, pages 368-374.
Crossref
Crossref
Lynne Vernice McFarland, Tarkan Karatas & Ali Karatas. (2021) Strain-Specific and Outcome-Specific Efficacy of Probiotics for the Treatment of Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis. SSRN Electronic Journal.
Crossref
Crossref